A.N. Solovyan.The possibilities of using of angiotensin-converting enzyme inhibitors in patients with hypertension and non-valvular atrial fibrillation: focus on enalapril.

This review presents risk factors of development of cardiovascular diseases, stratification of cardiovascular risk in patients with arterial hypertension, the data regarding influence of angiotensin-converting enzyme inhibitors upon activity of the renin-angiotensin-aldosterone system and their effectiveness in treatment of atrial hypertension and non-valvular atrial fibrillation. Beneficial influence of treatment with amiodarone and enalapril in patients with paroxysmal and persistent atrial fibrillation is shown.

Full article